The pontiff will give the traditional Angelus prayer and blessing in St Peter's Square on Sunday. #PopeLeoXIV #LungCancer #Vatican
www.bbc.co.uk
Pope to be discharged days after lung cancer surgery
The pontiff was diagnosed with lung cancer after having surgery at Rome's Gemelli Hospital on Tuesday. #PopeLeoXIV #LungCancer #Vatican
www.bbc.co.uk
Pope pictured for first time since surgery and cancer diagnosis
The pontiff was diagnosed with lung cancer after having surgery at Rome's Gemelli Hospital on Tuesday. #PopeLeoXIV #LungCancer #SuccessfulSurgery
www.bbc.co.uk
Pope pictured for first time since surgery and cancer diagnosis
The 71-year-old Pope was diagnosed with lung cancer after the 90-minute procedure on Tuesday. #PopeLeoXIV #LungCancer #HealthUpdate
www.bbc.co.uk
Pope walking and recovering 'as expected' after surgery, doctors say
The 71-year-old Pope was diagnosed with lung cancer after the 90-minute procedure on Tuesday. #PopeLeoXIV #LungCancer #HealthUpdate
www.bbc.co.uk
Pope walking and recovering 'as expected' after surgery, doctors say
The Pope is recovering in hospital after a successful surgery to remove part of his right lung. #PopeLeoXIV #LungCancer #VaticanCity
www.bbc.co.uk
What we know about the Pope's lung cancer diagnosis
Pope Leo XIV has undergone a successful operation in which part of his right lung was removed due to lung cancer. #Påven #Lungcancer #Vatikanen (translated)
www.corren.se
Påven har cancer – del av lunga bortopererad
Pope Leo XIV has been diagnosed with lung cancer after surgery to remove the lower lobe of his right lung, as confirmed by the Vatican. #PopeLeo #LungCancer #Vatican
www.rsvplive.ie
Pope Leo diagnosed with lung cancer after undergoing surgery, Vatican says
Pope Leo XIV has been diagnosed with lung cancer and has undergone surgery to remove a portion of a lung, the Vatican states. #PåveLeoXIV #lungcancer #Vatikanen (translated)
www.dn.se
Påve Leo har fått diagnosen lungcancer
Astra Zeneca har ingått ett exklusivt globalt licensavtal med Dizal Pharmaceutical för sin lungcancermedicin Zegfrovy (sunvozertinib), en oral EGFR-hämmare. #AstraZeneca #lungcancer #EGFRhæmmare
www.di.se
Nytt globalt avtal för Astra Zenecas lungcancermedel
Västra Götalandsregionen inför nya läkemedel och metoder för cancerbehandling och sällsynta sjukdomar, inklusive behandlingar för livmoderhalscancer och lungcancer, samt gentester för att optimera patientvården, med fokus på att förbättra kvalitet och patientsäkerhet. #VästraGötalandsregionen #cancerbehandling #sällsyntasjukdomar
via.tt.se
Nya läkemedel införs i Västra Götalandsregionen – satsning på cancerbehandling och sällsynta sjukdomar
Robert Berry, en snickare, upptäckte oväntat lungcancer under en årlig hälsokontroll vid Sophiahemmet 2016, vilket tack vare tidig diagnos gjorde att han kunde opereras framgångsrikt och nu är cancerfri, vilket han tillskriver betydelsen av regelbundna hälsokontroller. #Hälsokontroll #Cancer #Sjukvård
via.tt.se
”Hälsokontrollen fångade upp cancern i tid”
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A study published in JAMA Oncology reveals that more than half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as diagnostic delays, lack of access to oncologists, and social stigma, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A recent study revealed that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, highlighting barriers such as access, stigma, and diagnostic delays, despite significant advancements in drug options that have made the disease more treatable. #LungCancer #CancerTreatment #HealthEquity #US #TX
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A recent study revealed that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, highlighting barriers such as access, stigma, and diagnostic delays, despite significant advancements in drug options that have made the disease more treatable. #LungCancer #CancerTreatment #HealthEquity #US #TX
www.actualno.com
Голяма победа на Димитър Стоянов и BIRD.bg в съда срещу делата за натиск
A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US
www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US
www.faz.net
Nach Erdbeben: Zahl der Toten in Venezuela steigt auf rund 235
